Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Newcastle disease virus selectively kills human tumor cells.

Reichard KW, Lorence RM, Cascino CJ, Peeples ME, Walter RJ, Fernando MB, Reyes HM, Greager JA.

J Surg Res. 1992 May;52(5):448-53.

PMID:
1619912
2.

Complete regression of human neuroblastoma xenografts in athymic mice after local Newcastle disease virus therapy.

Lorence RM, Reichard KW, Katubig BB, Reyes HM, Phuangsab A, Mitchell BR, Cascino CJ, Walter RJ, Peeples ME.

J Natl Cancer Inst. 1994 Aug 17;86(16):1228-33.

PMID:
8040891
3.

Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy.

Lorence RM, Katubig BB, Reichard KW, Reyes HM, Phuangsab A, Sassetti MD, Walter RJ, Peeples ME.

Cancer Res. 1994 Dec 1;54(23):6017-21.

4.

Newcastle disease virus therapy of human tumor xenografts: antitumor effects of local or systemic administration.

Phuangsab A, Lorence RM, Reichard KW, Peeples ME, Walter RJ.

Cancer Lett. 2001 Oct 22;172(1):27-36.

PMID:
11595126
5.

Retinoic acid enhances killing of neuroblastoma cells by Newcastle disease virus.

Reichard KW, Lorence RM, Katubig BB, Peeples ME, Reyes HM.

J Pediatr Surg. 1993 Oct;28(10):1221-5; discussion 1225-6.

PMID:
8263678
6.

Antitumor effects of Newcastle Disease Virus in vivo: local versus systemic effects.

Schirrmacher V, Griesbach A, Ahlert T.

Int J Oncol. 2001 May;18(5):945-52.

PMID:
11295039
7.

[Anti-tumor effect of Newcastle disease virus strain D817 against nude mouse xenografts of human colon carcinoma].

Huang C, Fan XH, Jiang YH, Song DZ, Gao LQ, Huang QG, Lai ZP.

Zhonghua Zhong Liu Za Zhi. 2009 Jul;31(7):490-4. Chinese.

PMID:
19950694
8.
9.

Introduction of adhesive and costimulatory immune functions into tumor cells by infection with Newcastle Disease Virus.

Haas C, Ertel C, Gerhards R, Schirrmacher V.

Int J Oncol. 1998 Dec;13(6):1105-15.

PMID:
9824618
10.

Induction of cytokines and cytotoxicity against tumor cells by Newcastle disease virus.

Zorn U, Dallmann I, Grosse J, Kirchner H, Poliwoda H, Atzpodien J.

Cancer Biother. 1994 Fall;9(3):225-35.

PMID:
7820184
11.

Virus potentiation of tumor vaccine T-cell stimulatory capacity requires cell surface binding but not infection.

Schirrmacher V, Haas C, Bonifer R, Ertel C.

Clin Cancer Res. 1997 Jul;3(7):1135-48.

13.

[Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].

Li GC, Nie MM, Yang JM, Su CQ, Sun LC, Qian YZ, Sham J, Fang GE, Wu MC, Qian QJ.

Zhonghua Yi Xue Za Zhi. 2004 Jun 2;84(11):943-8. Chinese.

PMID:
15329284
14.

A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.

Li Y, Yu DC, Chen Y, Amin P, Zhang H, Nguyen N, Henderson DR.

Cancer Res. 2001 Sep 1;61(17):6428-36.

15.

Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.

Jacobs A, Tjuvajev JG, Dubrovin M, Akhurst T, Balatoni J, Beattie B, Joshi R, Finn R, Larson SM, Herrlinger U, Pechan PA, Chiocca EA, Breakefield XO, Blasberg RG.

Cancer Res. 2001 Apr 1;61(7):2983-95.

16.

Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy.

Jarnagin WR, Zager JS, Hezel M, Stanziale SF, Adusumilli PS, Gonen M, Ebright MI, Culliford A, Gusani NJ, Fong Y.

Cancer Gene Ther. 2006 Mar;13(3):326-34.

PMID:
16138120
18.

Effective treatment of head and neck squamous cell carcinoma by an oncolytic herpes simplex virus.

Wong RJ, Kim SH, Joe JK, Shah JP, Johnson PA, Fong Y.

J Am Coll Surg. 2001 Jul;193(1):12-21.

PMID:
11442249
19.

Newcastle disease virus LaSota strain kills human pancreatic cancer cells in vitro with high selectivity.

Walter RJ, Attar BM, Rafiq A, Tejaswi S, Delimata M.

JOP. 2012 Jan 10;13(1):45-53.

20.

Two avirulent, lentogenic strains of Newcastle disease virus are cytotoxic for some human pancreatic tumor lines in vitro.

Walter RJ, Attar BM, Rafiq A, Delimata M, Tejaswi S.

JOP. 2012 Sep 10;13(5):502-13. doi: 10.6092/1590-8577/977.

Supplemental Content

Support Center